BR

Beauty Ray

Active Director Director DIN 09723775
DIN 09723775 First appointment Sep 2022 Primary industry Chemicals
Unlock full profile Investments · shareholding · contact details
Current companies 1 active board seats
Total affiliations 1 Since Sep 2022
Shareholding value •••• Premium profile

About Beauty Ray

Data last updated:

Beauty Ray is a Director at Moonford Pharmaceuticals Private Limited (since 2022). The company operates in Chemicals. Moonford Pharmaceuticals Private Limited reported revenue of ₹36.8 Lakh (FY 2024).

DIN 09723775
Primary Designation Director
Industry Chemicals
First Appointment 01 Sep 2022
Oldest Company Age 4 yrs
Largest company Moonford Pharmaceuticals Private Limited · ₹36.8 Lakh (FY 2024)

Current companies

CompanyDesignationAppointmentFoundedRevenueStatus
Director01 Sep 20222022₹36.8 Lakh (FY 2024)Active

Board colleagues of Beauty Ray

NameDINCompanyDesignation
Sanjay Kumar09723776Moonford Pharmaceuticals Private LimitedDirector

Directorship timeline

Open interactive timeline →
Moonford Pharmaceuticals Private Limited
Premium access

Shareholding and investment profile for Beauty Ray

Company-level share counts, filed values, and quarterly changes require authenticated premium access.

  • Company-level holdings
  • Filed share counts
  • Reported values
  • Quarterly changes
Unlock shareholding

Verified entity values are shown only after access is granted.

Frequently Asked Questions about Beauty Ray

Beauty Ray currently holds 1 directorship: Moonford Pharmaceuticals Private Limited (Director, since 01 Sep 2022, revenue ₹36.8 Lakh (FY 2024)).

Beauty Ray was first appointed on 01 Sep 2022 as Director at Moonford Pharmaceuticals Private Limited.

The current boards of Beauty Ray's companies include Sanjay Kumar (Moonford Pharmaceuticals Private Limited).

Explore millions of companies — effortlessly

Access structured, verified intelligence on 7M+ companies across industries, sectors, and global markets. From early-stage startups to large enterprises, discover ownership, leadership, funding, financials, acquisitions, and market signals — all in one powerful platform.

Free account with essential features Instant access to company reports Enterprise solutions available